Loading... Please wait... Loading... Please wait...
ESTIMATED
05/14/2024
05/14/2024
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$5.56 | -$5.56 | -$5.56 |
| Q2 2024 | 1 | -$4.43 | -$4.43 | -$4.43 |
| Q3 2024 | 0 | -$1.78 | -$1.78 | -$1.78 |
| Q4 2024 | 0 | -$1.51 | -$1.51 | -$1.51 |
GeoVax Labs, Inc. last posted its earnings results on Tuesday, May 14th, 2024. The company reported $-2.47 earnings per share for the quarter, topping analysts' consensus estimates of $-5.56 by $3.09. The company had revenue of 0 for the quarter and had revenue of 0 for the year. GeoVax Labs, Inc. has generated $-14 earnings per share over the last year ($-14.29 diluted earnings per share) and currently has a price-to-earnings ratio of -0.27. GeoVax Labs, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/14/2024 | Q1 2024 | -$5.56 | -$2.47 | 3.09 | $0 | $0 | 02/29/2024 | Q4 2023 | -$3.60 | -$3.87 | -0.27 | $103,912 | $103,912 | 11/08/2023 | Q3 2023 | -$2.55 | -$4.75 | -2.2 | $0 | 08/09/2023 | Q2 2023 | -$2.40 | -$3.36 | -0.96 | $0 | 05/04/2023 | Q1 2023 | -$2.85 | -$2.17 | 0.68 | $0 | 03/23/2023 | Q4 2022 | -$2.55 | -$3.06 | -0.51 | $-81,526 | 11/09/2022 | Q3 2022 | -$1.80 | -$0.17 | 1.63 | $0 | 08/03/2022 | Q2 2022 | -$0.32 | -$0.18 | 0.14 | $0 | 04/27/2022 | Q1 2022 | -$0.31 | -$0.34 | -0.03 | $81,526 | 03/09/2022 | Q4 2021 | -$0.40 | -$2.16 | -1.76 | $164,962 | 11/12/2021 | Q3 2021 | -$0.31 | $30,414 | 08/11/2021 | Q2 2021 | -$0.43 | -$0.21 | 0.22 | $79,708 | 05/06/2021 | Q1 2021 | -$0.29 | $110,417 | 03/23/2021 | Q4 2020 | -$0.04 | -$0.25 | -0.21 | $400,000 | $251,621 | 11/05/2020 | Q3 2020 | -$0.73 | $415,458 | 08/10/2020 | Q2 2020 | -$0.66 | $440,602 | 05/05/2020 | Q1 2020 | -$2.54 | $715,977 | 03/24/2020 | Q4 2019 | -$2.52 | $300,000 | $268,514 | 11/07/2019 | Q3 2019 | -$485,757.10 | -$177.59 | 485579.51 | $300,000 | $333,209 | 08/13/2019 | Q2 2019 | -$32,707.40 | $300,000 | $209,941 |
|---|
A. GeoVax Labs, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates.
A. In the previous quarter, GeoVax Labs, Inc. (NASDAQ:GOVX) reported $-2.47 earnings per share (EPS) to beat the analysts' consensus estimate of $-5.56 by $3.09.
A. The conference call for GeoVax Labs, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for GeoVax Labs, Inc.'s latest earnings report can be read online.
A. GeoVax Labs, Inc. (NASDAQ:GOVX) has a recorded net income of $0. GeoVax Labs, Inc. has generated $-14.29 earnings per share over the last four quarters.
A. GeoVax Labs, Inc. (NASDAQ:GOVX) has a price-to-earnings ratio of -0.27 and price/earnings-to-growth ratio is 0.02.
